Novel Agent Active Across Heavily Pretreated HER2+ Tumors

This topic has 0 replies, 1 voice, and was last updated 5 years, 4 months ago by gavin.

Viewing 1 post (of 1 total)

Author

Posts
December 3, 2018 at 10:26 am #97856

gavin
Moderator

Novel Agent Active Across Heavily Pretreated HER2+ Tumors

https://www.onclive.com/web-exclusives/novel-agent-active-across-heavily-pretreated-her2-tumors?utm_medium=email&utm_campaign=ONCSS%20GI%20CC%20eNews%20%20Cyramza%20Eli%20Lilly%20%2011-28-18&utm_content=ONCSS%20GI%20CC%20eNews%20%20Cyramza%20Eli%20Lilly%20%2011-28-18+CID_7e9820ab551cadf1dc7189750b7ed4d1&utm_source=CM%20ONCLIVE&utm_term=Novel%20Agent%20Active%20Across%20Heavily%20Pretreated%20HER2%20Tumors

Thanks to OncLive 2006-2018 Intellisphere, LLC for this piece.

Gavin
Author

Posts

Viewing 1 post (of 1 total)

The forum ‘Websites’ is closed to new topics and replies.

©2022 - All Rights Reserved, Cholangiocarcinoma Foundation